+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Asia Pacific Remote Healthcare Market Size, Share & Trends Analysis Report By Service (Tele-ICU, Real Time Virtual Health and Remote Patient Monitoring), By End Use, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 150 Pages
  • September 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 6007549
The Asia Pacific Remote Healthcare Market would witness market growth of 17.2% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Remote Healthcare Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.55 billion by 2031. The Japan market is registering a CAGR of 16.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 18% during (2024 - 2031).



Tele-ICU services are enhancing remote monitoring and management of intensive care units (ICUs). This application enables intensivists to oversee multiple ICUs from a centralized location, improving patient care and optimizing ICU resource utilization.

Moreover, tele-rehabilitation services offer physical therapy and rehabilitation exercises through video consultations. This application provides patients with access to therapeutic exercises and guidance from rehabilitation specialists without needing to travel to a physical clinic.

China’s rapidly aging population drives the demand for healthcare services, including remote healthcare. The prevalence of chronic diseases is on the rise as the senior population increases, which requires ongoing health monitoring and management. This demographic shift is creating a substantial market for remote healthcare solutions that can provide convenient and effective care for older adults. As per the Shanghai Municipal People's Government, there are 190 million older people in the nation, and they have the highest incidence of chronic disease. About 75 percent of people over 60 years old have one chronic disease, and 43 percent have at least two chronic diseases.

Based on Service, the market is segmented into Tele-ICU, Real Time Virtual Health (Video Communication, Audio Communication, and Email/Chat box), and Remote Patient Monitoring. Based on End Use, the market is segmented into Provider, Payer, Patient, and Employer Groups & Government Organizations. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Abbott Laboratories
  • GE HealthCare Technologies, Inc.
  • American Well Corporation (Amwell)
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Teladoc Health, Inc.
  • Honeywell International, Inc.
  • Resideo Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Oracle Corporation

Market Report Segmentation

By

Service

  • Tele-ICU
  • Real Time Virtual Health
  • Video Communication
  • Audio Communication
  • Email/Chat box
  • Remote Patient Monitoring

By End Use

  • Provider
  • Payer
  • Patient
  • Employer Groups & Government Organizations

By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Remote Healthcare Market, by Service
1.4.2 Asia Pacific Remote Healthcare Market, by End Use
1.4.3 Asia Pacific Remote Healthcare Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Sep - 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Asia Pacific Remote Healthcare Market by Service
5.1 Asia Pacific Tele-ICU Market by Country
5.2 Asia Pacific Real Time Virtual Health Market by Country
5.2.1 Asia Pacific Remote Healthcare Market by Real Time Virtual Health Type
5.2.2 Asia Pacific Video Communication Market by Country
5.2.3 Asia Pacific Audio Communication Market by Country
5.2.4 Asia Pacific Email/Chat box Market by Country
5.3 Asia Pacific Remote Patient Monitoring Market by Country
Chapter 6. Asia Pacific Remote Healthcare Market by End Use
6.1 Asia Pacific Provider Market by Country
6.2 Asia Pacific Payer Market by Country
6.3 Asia Pacific Patient Market by Country
6.4 Asia Pacific Employer Groups & Government Organizations Market by Country
Chapter 7. Asia Pacific Remote Healthcare Market by Country
7.1 China Remote Healthcare Market
7.1.1 China Remote Healthcare Market by Service
7.1.1.1 China Remote Healthcare Market by Real Time Virtual Health Type
7.1.2 China Remote Healthcare Market by End Use
7.2 Japan Remote Healthcare Market
7.2.1 Japan Remote Healthcare Market by Service
7.2.1.1 Japan Remote Healthcare Market by Real Time Virtual Health Type
7.2.2 Japan Remote Healthcare Market by End Use
7.3 India Remote Healthcare Market
7.3.1 India Remote Healthcare Market by Service
7.3.1.1 India Remote Healthcare Market by Real Time Virtual Health Type
7.3.2 India Remote Healthcare Market by End Use
7.4 South Korea Remote Healthcare Market
7.4.1 South Korea Remote Healthcare Market by Service
7.4.1.1 South Korea Remote Healthcare Market by Real Time Virtual Health Type
7.4.2 South Korea Remote Healthcare Market by End Use
7.5 Australia Remote Healthcare Market
7.5.1 Australia Remote Healthcare Market by Service
7.5.1.1 Australia Remote Healthcare Market by Real Time Virtual Health Type
7.5.2 Australia Remote Healthcare Market by End Use
7.6 Malaysia Remote Healthcare Market
7.6.1 Malaysia Remote Healthcare Market by Service
7.6.1.1 Malaysia Remote Healthcare Market by Real Time Virtual Health Type
7.6.2 Malaysia Remote Healthcare Market by End Use
7.7 Rest of Asia Pacific Remote Healthcare Market
7.7.1 Rest of Asia Pacific Remote Healthcare Market by Service
7.7.1.1 Rest of Asia Pacific Remote Healthcare Market by Real Time Virtual Health Type
7.7.2 Rest of Asia Pacific Remote Healthcare Market by End Use
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 American Well Corporation (Amwell)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expenses
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.3.4.2 Product Launches and Product Expansions:
8.3.5 SWOT Analysis
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Teladoc Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.6 SWOT Analysis
8.7 Honeywell International, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 Resideo Technologies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Oracle Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
8.10.6 SWOT Analysis

Companies Mentioned

  • Abbott Laboratories
  • GE HealthCare Technologies, Inc.
  • American Well Corporation (Amwell)
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Teladoc Health, Inc.
  • Honeywell International, Inc.
  • Resideo Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Oracle Corporation

Methodology

Loading
LOADING...